Approval
Triple Combination Treatments for Multiple Myeloma Approved in Europe
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M05-19-NI-027May 29, 2019
Approval
European Commission Approved Tecentriq/Avastin Combination Therapy for Lung Cancer
Pharma's Almanac
PAO-M03-19-NI-018-2902Mar 12, 2019
Combination Treatment
MedImmune, NeoTX to Study Combination Treatment
Emilie Branch
Pharma's Almanac
PAO-M02-19-NI-016Feb 19, 2019
Drug Development
Mylan to Introduce Two New Cost-Saving HIV Combination Treatments in the U.S.
Mylan
PR-M03-18-NI-023Mar 07, 2018
Breakthrough Therapy
Eisai and Merck Receive Breakthrough Therapy Designation from FDA for LENVIMA® (lenvatinib mesylate) and KEYTRUDA® (pembrolizumab) as Combination Therapy
Eisai
PR-M01-18-NI-032Jan 12, 2018
Combination Therapy
Researchers at the University of Colorado Develop New Combination Hepatitis C Treatment
Emilie Branch
Pharma's Almanac
PAO-M08-17-NI-035Aug 25, 2017
Oncology
Quadruple Myeloma Combination Treatment Study Begins
Guy Tiene
Nice Insight
PAO-M08-17-NI-027Aug 17, 2017
Drug Development
New Partnership Targets Colorectal Cancer with Combination Therapy, Including Avelumab
Guy Tiene
Nice Insight
PAO-M06-17-NI-020Jun 29, 2017